The IL-2 cytokine family in cancer immunotherapy
The DOI matches its Crossref record; 183 of the 183 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regulatory T cells: mechanisms of differentiation and function
Josefowicz, S. Z., Lu, L.-F., & Rudensky, A. Y. (2012) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141623 · Cited by 2,866 · cited 1×
“Treg and is a master regulator of the development of both natural (nTreg) and induced Treg (iTreg) [16,78].”
BackgroundCancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes
Dudley, M. E., Wunderlich, J. R., Robbins, P. F., Yang, J. C., Hwu, P., Schwartzentruber, D. J., Topalian, S. L., Sherry, R., Restifo, N. P., Hubicki, A. M., et al. (2002) · Science · doi:10.1126/science.1076514 · Cited by 2,823
Grimm, E. A., Mazumder, A., Zhang, H. Z., & Rosenberg, S. A. (1982) · The Journal of experimental medicine · doi:10.1084/jem.155.6.1823 · Cited by 2,204
Adoptive immunotherapy for cancer: harnessing the T cell response
Restifo, N. P., Dudley, M. E., & Rosenberg, S. A. (2012) · Nature Reviews Immunology · doi:10.1038/nri3191 · Cited by 1,688 · cited 1×
“free from disease for almost 8 years after HD IL-2 and TIL therapy (Table 1) [125].”
BackgroundDudley, M. E., Wunderlich, J. R., Yang, J. C., Sherry, R. M., Topalian, S. L., Restifo, N. P., Royal, R. E., Kammula, U., White, D. E., Mavroukakis, S. A., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.00.240 · Cited by 1,639
Reversible Defects in Natural Killer and Memory Cd8 T Cell Lineages in Interleukin 15–Deficient Mice
Kennedy, M. K., Glaccum, M., Brown, S. N., Butz, E. A., Viney, J. L., Embers, M., Matsuki, N., Charrier, K., Sedger, L., Willis, C. R., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.5.771 · Cited by 1,634
Essential autocrine regulation by IL-21 in the generation of inflammatory T cells
Nurieva, R., Yang, X. O., Martinez, G., Zhang, Y., Panopoulos, A. D., Ma, L., Schluns, K., Tian, Q., Watowich, S. S., Jetten, A. M., et al. (2007) · Nature · doi:10.1038/nature05969 · Cited by 1,466
Cloning of a T Cell Growth Factor that Interacts with the β Chain of the Interleukin-2 Receptor
Grabstein, K. H., Eisenman, J., Shanebeck, K., Rauch, C., Srinivasan, S., Fung, V., Beers, C., Richardson, J., Schoenborn, M. A., Ahdieh, M., et al. (1994) · Science · doi:10.1126/science.8178155 · Cited by 1,422
Dudley, M. E., Yang, J. C., Sherry, R., Hughes, M. S., Royal, R., Kammula, U., Robbins, P. F., Huang, J., Citrin, D. E., Leitman, S. F., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.5449 · Cited by 1,332
IL-15 Receptor Maintains Lymphoid Homeostasis by Supporting Lymphocyte Homing and Proliferation
Lodolce, J. P., Boone, D. L., Chai, S., Swain, R. E., Dassopoulos, T., Trettin, S., & Ma, A. (1998) · Immunity · doi:10.1016/s1074-7613(00)80664-0 · Cited by 1,299
IL-2: The First Effective Immunotherapy for Human Cancer
Rosenberg, S. A. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1490019 · Cited by 1,289
Potent and Selective Stimulation of Memory-Phenotype CD8+ T Cells In Vivo by IL-15
Zhang, X., Sun, S., Hwang, I., Tough, D. F., & Sprent, J. (1998) · Immunity · doi:10.1016/s1074-7613(00)80564-6 · Cited by 1,245
Parrish-Novak, J., Dillon, S. R., Nelson, A., Hammond, A., Sprecher, C., Gross, J. A., Johnston, J., Madden, K., Xu, W., West, J., et al. (2000) · Nature · doi:10.1038/35040504 · Cited by 1,224
Malek, T. R. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090357 · Cited by 1,079 · cited 5×
“Moreover, mice deficient in IL-2, IL-2Ra, or IL-2Rb develop spontaneous lethal autoimmune disease that can be prevented by adoptive transfer of wild-type CD4+CD25+ Treg [1,82].”
BackgroundInfluentialExperience with the Use of High-Dose Interleukin-2 in the Treatment of 652 Cancer Patients
ROSENBERG, S. A., LOTZE, M. T., YANG, J. C., AEBERSOLD, P. M., LINEHAN, W. M., SEIPP, C. A., & WHITE, D. E. (1989) · Annals of Surgery · doi:10.1097/00000658-198910000-00008 · Cited by 1,002
Deacetylase inhibition promotes the generation and function of regulatory T cells
Tao, R., de Zoeten, E. F., Özkaynak, E., Chen, C., Wang, L., Porrett, P. M., Li, B., Turka, L. A., Olson, E. N., Greene, M. I., et al. (2007) · Nature Medicine · doi:10.1038/nm1652 · Cited by 924
gp100 Peptide Vaccine and Interleukin-2 in Patients with Advanced Melanoma
Schwartzentruber, D. J., Lawson, D. H., Richards, J. M., Conry, R. M., Miller, D. M., Treisman, J., Gailani, F., Riley, L., Conlon, K., Pockaj, B., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1012863 · Cited by 911
Cloning of the γ Chain of the Human IL-2 Receptor
Takeshita, T., Asao, H., Ohtani, K., Ishii, N., Kumaki, S., Tanaka, N., Munakata, H., Nakamura, M., & Sugamura, K. (1992) · Science · doi:10.1126/science.1631559 · Cited by 840
McDermott, D. F., Regan, M. M., Clark, J. I., Flaherty, L. E., Weiss, G. R., Logan, T. F., Kirkwood, J. M., Gordon, M. S., Sosman, J. A., Ernstoff, M. S., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.206 · Cited by 820
Interleukin-2 signals during priming are required for secondary expansion of CD8+ memory T cells
Williams, M. A., Tyznik, A. J., & Bevan, M. J. (2006) · Nature · doi:10.1038/nature04790 · Cited by 797
Pipkin, M. E., Sacks, J. A., Cruz-Guilloty, F., Lichtenheld, M. G., Bevan, M. J., & Rao, A. (2010) · Immunity · doi:10.1016/j.immuni.2009.11.012 · Cited by 795
Rudensky, A. Y. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01018.x · Cited by 765
Xu, Y., Zhang, M., Ramos, C. A., Durett, A., Liu, E., Dakhova, O., Liu, H., Creighton, C. J., Gee, A. P., Heslop, H. E., et al. (2014) · Blood · doi:10.1182/blood-2014-01-552174 · Cited by 744
Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and function
Zeng, R., Spolski, R., Finkelstein, S. E., Oh, S., Kovanen, P. E., Hinrichs, C. S., Pise-Masison, C. A., Radonovich, M. F., Brady, J. N., Restifo, N. P., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041057 · Cited by 727
Bauquet, A. T., Jin, H., Paterson, A. M., Mitsdoerffer, M., Ho, I.-C., Sharpe, A. H., & Kuchroo, V. K. (2009) · Nature Immunology · doi:10.1038/ni.1690 · Cited by 713 · cited 1×
“IL-21 is predominantly produced by TFH cells and it promotes TFH lineage commitment via upregulation of transcription factors Bcl-6 and c-Maf [99].”
BackgroundInterleukin-21: Basic Biology and Implications for Cancer and Autoimmunity
Spolski, R., & Leonard, W. J. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090316 · Cited by 696
Membrane-Bound IL-21 Promotes Sustained Ex Vivo Proliferation of Human Natural Killer Cells
Denman, C. J., Senyukov, V. V., Somanchi, S. S., Phatarpekar, P. V., Kopp, L. M., Johnson, J. L., Singh, H., Hurton, L., Maiti, S. N., Huls, M. H., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030264 · Cited by 683
Ozaki, K., Spolski, R., Ettinger, R., Kim, H.-P., Wang, G., Qi, C.-F., Hwu, P., Shaffer, D. J., Akilesh, S., Roopenian, D. C., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.9.5361 · Cited by 668
A Two-Step Process for Thymic Regulatory T Cell Development
Lio, C.-W. J., & Hsieh, C.-S. (2008) · Immunity · doi:10.1016/j.immuni.2007.11.021 · Cited by 661
IL-21 Is Produced by Th17 Cells and Drives IL-17 Production in a STAT3-dependent Manner
Wei, L., Laurence, A., Elias, K. M., & O'Shea, J. J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705100200 · Cited by 641
IL-2 administration increases CD4+CD25hi Foxp3+ regulatory T cells in cancer patients
Ahmadzadeh, M., & Rosenberg, S. A. (2006) · Blood · doi:10.1182/blood-2005-06-2399 · Cited by 632
IL-15 enhances the in vivo antitumor activity of tumor-reactive CD8 + T Cells
Klebanoff, C. A., Finkelstein, S. E., Surman, D. R., Lichtman, M. K., Gattinoni, L., Theoret, M. R., Grewal, N., Spiess, P. J., Antony, P. A., Palmer, D. C., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307298101 · Cited by 577
Harnessing the biology of IL-7 for therapeutic application
Mackall, C. L., Fry, T. J., & Gress, R. E. (2011) · Nature Reviews Immunology · doi:10.1038/nri2970 · Cited by 571
Hoyos, V, Savoldo, B., Quintarelli, C., Mahendravada, A., Zhang, M., Vera, J., Heslop, H. E., Rooney, C. M., Brenner, M. K., & Dotti, G. (2010) · Leukemia · doi:10.1038/leu.2010.75 · Cited by 567
Exploiting a natural conformational switch to engineer an interleukin-2 ‘superkine’
Levin, A. M., Bates, D. L., Ring, A. M., Krieg, C., Lin, J. T., Su, L., Moraga, I., Raeber, M. E., Bowman, G. R., Novick, P., et al. (2012) · Nature · doi:10.1038/nature10975 · Cited by 552
Interleukin-21: a double-edged sword with therapeutic potential
Spolski, R., & Leonard, W. J. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4296 · Cited by 548
Cutting Edge: The Common γ-Chain Is an Indispensable Subunit of the IL-21 Receptor Complex
Asao, H., Okuyama, C., Kumaki, S., Ishii, N., Tsuchiya, S., Foster, D., & Sugamura, K. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.1.1 · Cited by 541
Simultaneous production of IL-2, IL-4, and IFN-gamma by activated human CD4+ and CD8+ T cell clones.
Paliard, X., de Waal Malefijt, R., Yssel, H., Blanchard, D., Chrétien, I., Abrams, J., de Vries, J., & Spits, H. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.141.3.849 · Cited by 512
Maker, A. V., Phan, G. Q., Attia, P., Yang, J. C., Sherry, R. M., Topalian, S. L., Kammula, U. S., Royal, R. E., Haworth, L. R., Levy, C., et al. (2005) · Annals of Surgical Oncology · doi:10.1245/aso.2005.03.536 · Cited by 492
Rosenberg, S. A., Yang, J. C., White, D. E., & Steinberg, S. M. (1998) · Annals of Surgery · doi:10.1097/00000658-199809000-00004 · Cited by 485
Transcriptional regulation of Th17 cell differentiation
Ivanov, I. I., Zhou, L., & Littman, D. R. (2007) · Seminars in Immunology · doi:10.1016/j.smim.2007.10.011 · Cited by 484
IL-21 Limits NK Cell Responses and Promotes Antigen-Specific T Cell Activation
Kasaian, M. T., Whitters, M. J., Carter, L. L., Lowe, L. D., Jussif, J. M., Deng, B., Johnson, K. A., Witek, J. S., Senices, M., Konz, R. F., et al. (2002) · Immunity · doi:10.1016/s1074-7613(02)00295-9 · Cited by 481
Biology of the Interleukin-2 Receptor
Nelson, B. H., & Willerford, D. M. (1998) · Advances in Immunology · doi:10.1016/s0065-2776(08)60386-7 · Cited by 475
Pot, C., Jin, H., Awasthi, A., Liu, S. M., Lai, C.-Y., Madan, R., Sharpe, A. H., Karp, C. L., Miaw, S.-C., Ho, I.-C., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901233 · Cited by 467
IL-2 and IL-21 confer opposing differentiation programs to CD8+ T cells for adoptive immunotherapy
Hinrichs, C. S., Spolski, R., Paulos, C. M., Gattinoni, L., Kerstann, K. W., Palmer, D. C., Klebanoff, C. A., Rosenberg, S. A., Leonard, W. J., & Restifo, N. P. (2008) · Blood · doi:10.1182/blood-2007-09-113050 · Cited by 462
Besser, M. J., Shapira-Frommer, R., Treves, A. J., Zippel, D., Itzhaki, O., Hershkovitz, L., Levy, D., Kubi, A., Hovav, E., Chermoshniuk, N., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0041 · Cited by 462
Mattei, F., Schiavoni, G., Belardelli, F., & Tough, D. F. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.3.1179 · Cited by 459
The IL-2 Receptor β Chain (p70): Role in Mediating Signals for LAK, NK, and Proliferative Activities
Siegel, J. P., Sharon, M., Smith, P. L., & Leonard, W. J. (1987) · Science · doi:10.1126/science.3116668 · Cited by 445
Waldmann, T. (2001) · Immunity · doi:10.1016/s1074-7613(09)00091-0 · Cited by 434
IL-2-induced activation-induced cell death is inhibited in IL-15 transgenic mice
Marks-Konczalik, J., Dubois, S., Losi, J. M., Sabzevari, H., Yamada, N., Feigenbaum, L., Waldmann, T. A., & Tagaya, Y. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.200363097 · Cited by 433
Radvanyi, L. G., Bernatchez, C., Zhang, M., Fox, P. S., Miller, P., Chacon, J., Wu, R., Lizee, G., Mahoney, S., Alvarado, G., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1177 · Cited by 427
Self-citationBurchill, M. A., Yang, J., Vang, K. B., Moon, J. J., Chu, H. H., Lio, C.-W. J., Vegoe, A. L., Hsieh, C.-S., Jenkins, M. K., & Farrar, M. A. (2008) · Immunity · doi:10.1016/j.immuni.2007.11.022 · Cited by 418
Odegard, J. M., Marks, B. R., DiPlacido, L. D., Poholek, A. C., Kono, D. H., Dong, C., Flavell, R. A., & Craft, J. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080840 · Cited by 418
Cui, W., Liu, Y., Weinstein, J. S., Craft, J., & Kaech, S. M. (2011) · Immunity · doi:10.1016/j.immuni.2011.09.017 · Cited by 410 · cited 1×
“STAT3 activation [193].”
Human immune disorder arising from mutation of the α chain of the interleukin-2 receptor
Sharfe, N., Dadi, H. K., Shahar, M., & Roifman, C. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.7.3168 · Cited by 409
The interleukin 2 receptor. Functional consequences of its bimolecular structure.
Wang, H. M., & Smith, K. A. (1987) · The Journal of experimental medicine · doi:10.1084/jem.166.4.1055 · Cited by 400
IL-21 in Synergy with IL-15 or IL-18 Enhances IFN-γ Production in Human NK and T Cells
Strengell, M., Matikainen, S., Sirén, J., Lehtonen, A., Foster, D., Julkunen, I., & Sareneva, T. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.11.5464 · Cited by 394
Cytokines and immunodeficiency diseases
Leonard, W. J. (2001) · Nature Reviews Immunology · doi:10.1038/35105066 · Cited by 390
Krieg, C., Létourneau, S., Pantaleo, G., & Boyman, O. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002569107 · Cited by 380
Combined IL-15/IL-15Rα Immunotherapy Maximizes IL-15 Activity In Vivo
Stoklasek, T. A., Schluns, K. S., & Lefrançois, L. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.9.6072 · Cited by 366
IL-21 Is Produced by NKT Cells and Modulates NKT Cell Activation and Cytokine Production
Coquet, J. M., Kyparissoudis, K., Pellicci, D. G., Besra, G., Berzins, S. P., Smyth, M. J., & Godfrey, D. I. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.5.2827 · Cited by 364
IL-15 Promotes the Survival of Naive and Memory Phenotype CD8+ T Cells
Berard, M., Brandt, K., Paus, S. B., & Tough, D. F. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.10.5018 · Cited by 343
Both integrated and differential regulation of components of the IL-2/IL-2 receptor system
Kim, H. P., Imbert, J., & Leonard, W. J. (2006) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2006.07.003 · Cited by 325
Induction and regulation of IL-15 expression in murine macrophages
Doherty, T. M., Seder, R. A., & Sher, A. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.2.735 · Cited by 323
Atkins, M. B., Hsu, J., Lee, S., Cohen, G. I., Flaherty, L. E., Sosman, J. A., Sondak, V. K., & Kirkwood, J. M. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.5448 · Cited by 320
Mortier, E., Woo, T., Advincula, R., Gozalo, S., & Ma, A. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071913 · Cited by 316
Carnemolla, B., Borsi, L., Balza, E., Castellani, P., Meazza, R., Berndt, A., Ferrini, S., Kosmehl, H., Neri, D., & Zardi, L. (2002) · Blood · doi:10.1182/blood.v99.5.1659 · Cited by 296
Kessel, A., Haj, T., Peri, R., Snir, A., Melamed, D., Sabo, E., & Toubi, E. (2012) · Autoimmunity Reviews · doi:10.1016/j.autrev.2011.11.018 · Cited by 295
The hematopoietin receptor superfamily
Cosman, D. (1993) · Cytokine · doi:10.1016/1043-4666(93)90047-9 · Cited by 295
IL-21 Influences the Frequency, Phenotype, and Affinity of the Antigen-Specific CD8 T Cell Response
Li, Y., Bleakley, M., & Yee, C. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.4.2261 · Cited by 273
Moroz, A., Eppolito, C., Li, Q., Tao, J., Clegg, C. H., & Shrikant, P. A. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.2.900 · Cited by 268
In vivo antitumor activity of interleukin 21 mediated by natural killer cells.
Wang, G., Tschoi, M., Spolski, R. J., Lou, Y., Ozaki, K., Feng, C., Kim, G., Leonard, W. J., & Hwu, P. (2003) · PubMed · Cited by 249
Mechanistic and structural insight into the functional dichotomy between IL-2 and IL-15
Ring, A. M., Lin, J.-X., Feng, D., Mitra, S., Rickert, M., Bowman, G. R., Pande, V. S., Li, P., Moraga, I., Spolski, R., et al. (2012) · Nature Immunology · doi:10.1038/ni.2449 · Cited by 248
Interleukin-21 inhibits dendritic cell activation and maturation
Brandt, K., Bulfone-Paus, S., Foster, D. C., & Rückert, R. (2003) · Blood · doi:10.1182/blood-2003-03-0669 · Cited by 245
Safety and immunologic effects of IL-15 administration in nonhuman primates
Berger, C., Berger, M., Hackman, R. C., Gough, M., Elliott, C., Jensen, M. C., & Riddell, S. R. (2009) · Blood · doi:10.1182/blood-2008-12-189266 · Cited by 244
TGF‐β‐producing regulatory B cells induce regulatory T cells and promote transplantation tolerance
Lee, K. M., Stott, R. T., Zhao, G., SooHoo, J., Xiong, W., Lian, M. M., Fitzgerald, L., Shi, S., Akrawi, E., Lei, J., et al. (2014) · European Journal of Immunology · doi:10.1002/eji.201344062 · Cited by 236
Mortier, E., Advincula, R., Kim, L., Chmura, S., Barrera, J., Reizis, B., Malynn, B. A., & Ma, A. (2009) · Immunity · doi:10.1016/j.immuni.2009.09.017 · Cited by 235
Oppenheimer-Marks, N., Brezinschek, R. I., Mohamadzadeh, M., Vita, R., & Lipsky, P. E. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1986 · Cited by 229
IL-2 therapy promotes suppressive ICOS+ Treg expansion in melanoma patients
Sim, G. C., Martin-Orozco, N., Jin, L., Yang, Y., Wu, S., Washington, E., Sanders, D., Lacey, C., Wang, Y., Vence, L., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci46266 · Cited by 229
Self-citationDepper, J. M., Leonard, W. J., Krönke, M., Noguchi, P. D., Cunningham, R. E., Waldmann, T. A., & Greene, W. C. (1984) · The Journal of Immunology · doi:10.4049/jimmunol.133.6.3054 · Cited by 227
Loss-of-function mutations in the IL-21 receptor gene cause a primary immunodeficiency syndrome
Kotlarz, D., Ziętara, N., Uzel, G., Weidemann, T., Braun, C. J., Diestelhorst, J., Krawitz, P. M., Robinson, P. N., Hecht, J., Puchałka, J., et al. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20111229 · Cited by 218
Yu, P., Steel, J. C., Zhang, M., Morris, J. C., & Waldmann, T. A. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1966 · Cited by 213
The Structure of Interleukin-2 Complexed with Its Alpha Receptor
Rickert, M., Wang, X., Boulanger, M. J., Goriatcheva, N., & Garcia, K. C. (2005) · Science · doi:10.1126/science.1109745 · Cited by 212
Interleukin-2 as a neuroregulatory cytokine
Hanisch, U.-K., & Quirion, R. (1995) · Brain Research Reviews · doi:10.1016/0165-0173(95)00015-1 · Cited by 211
Tagaya, Y., Kurys, G., Thies, T. A., Losi, J. M., Azimi, N., Hanover, J. A., Bamford, R. N., & Waldmann, T. A. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.26.14444 · Cited by 209
Involvement of interleukin-21 in the epidermal hyperplasia of psoriasis
Caruso, R., Botti, E., Sarra, M., Esposito, M., Stolfi, C., Diluvio, L., Giustizieri, M. L., Pacciani, V., Mazzotta, A., Campione, E., et al. (2009) · Nature Medicine · doi:10.1038/nm.1995 · Cited by 206
Yao, X., Ahmadzadeh, M., Lu, Y.-C., Liewehr, D. J., Dudley, M. E., Liu, F., Schrump, D. S., Steinberg, S. M., Rosenberg, S. A., & Robbins, P. F. (2012) · Blood · doi:10.1182/blood-2011-10-386482 · Cited by 206
Singh, H., Figliola, M. J., Dawson, M. J., Huls, H., Olivares, S., Switzer, K., Mi, T., Maiti, S., Kebriaei, P., Lee, D. A., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3843 · Cited by 199
Waldmann, T. A., Lugli, E., Roederer, M., Perera, L. P., Smedley, J. V., Macallister, R. P., Goldman, C. K., Bryant, B. R., Decker, J. M., Fleisher, T. A., et al. (2011) · Blood · doi:10.1182/blood-2010-10-311456 · Cited by 195
Thompson, J. A., Curti, B. D., Redman, B. G., Bhatia, S., Weber, J. S., Agarwala, S. S., Sievers, E. L., Hughes, S. D., DeVries, T. A., & Hausman, D. F. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.5193 · Cited by 187
Control of matrix metalloproteinase production in human intestinal fibroblasts by interleukin 21
Monteleone, G., Caruso, R., Fina, D., Peluso, I., Gioia, V, Stolfi, C., Fantini, M. C., Caprioli, F., Tersigni, R., Alessandroni, L., et al. (2006) · Gut · doi:10.1136/gut.2006.093187 · Cited by 186
IL-21 Mediates Suppressive Effects via Its Induction of IL-10
Spolski, R., Kim, H.-P., Zhu, W., Levy, D. E., & Leonard, W. J. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802978 · Cited by 182
Regulation of IL-15 secretion via the leader peptide of two IL-15 isoforms
Onu, A., Pohl, T., Krause, H., & Bulfone-Paus, S. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.1.255 · Cited by 180
Osenga, K. L., Hank, J. A., Albertini, M. R., Gan, J., Sternberg, A. G., Eickhoff, J., Seeger, R. C., Matthay, K. K., Reynolds, C. P., Twist, C., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2000 · Cited by 180
IL-1β and IL-2 convert human Treg into TH17 cells
Deknuydt, F., Bioley, G., Valmori, D., & Ayyoub, M. (2009) · Clinical Immunology · doi:10.1016/j.clim.2008.12.008 · Cited by 179
Clark, R. A., & Kupper, T. S. (2007) · Blood · doi:10.1182/blood-2006-02-002873 · Cited by 179
Characterization of the IL-15 niche in primary and secondary lymphoid organs in vivo
Cui, G., Hara, T., Simmons, S., Wagatsuma, K., Abe, A., Miyachi, H., Kitano, S., Ishii, M., Tani-ichi, S., & Ikuta, K. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1318281111 · Cited by 178
Maier, L. M., Anderson, D. E., Severson, C. A., Baecher-Allan, C., Healy, B., Liu, D. V., Wittrup, K. D., De Jager, P. L., & Hafler, D. A. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.3.1541 · Cited by 175
Differential regulation of T-cell growth by IL-2 and IL-15
Cornish, G. H., Sinclair, L. V., & Cantrell, D. A. (2006) · Blood · doi:10.1182/blood-2005-12-4827 · Cited by 173
Interleukin 2 receptor gene expression in normal human T lymphocytes.
Leonard, W. J., Krönke, M., Peffer, N. J., Depper, J. M., & Greene, W. C. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.18.6281 · Cited by 164
T‐cell memory differentiation: insights from transcriptional signatures and epigenetics
Youngblood, B., Hale, J. S., & Ahmed, R. (2013) · Immunology · doi:10.1111/imm.12074 · Cited by 164
Davis, I. D., Skrumsager, B. K., Cebon, J., Nicholaou, T., Barlow, J. W., Moller, N. P. H., Skak, K., Lundsgaard, D., Frederiksen, K. S., Thygesen, P., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0410 · Cited by 164
Ma, H.-L., Whitters, M. J., Konz, R. F., Senices, M., Young, D. A., Grusby, M. J., Collins, M., & Dunussi-Joannopoulos, K. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.2.608 · Cited by 162
Site-Directed Pegylation of Recombinant Interleukin-2 at its Glycosylation Site
Goodson, R. J., & Katre, N. V. (1990) · Nature Biotechnology · doi:10.1038/nbt0490-343 · Cited by 159
IL-15 availability conditions homeostasis of peripheral natural killer T cells
Ranson, T., Vosshenrich, C. A. J., Corcuff, E., Richard, O., Laloux, V., Lehuen, A., & Santo, J. P. D. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0535482100 · Cited by 156
Huang, J., Kerstann, K. W., Ahmadzadeh, M., Li, Y. F., El-Gamil, M., Rosenberg, S. A., & Robbins, P. F. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.12.7726 · Cited by 154
IL-15Rα expression on CD8 + T cells is dispensable for T cell memory
Burkett, P. R., Koka, R. M., Chien, M., Chai, S., Chan, F., Ma, A. I., & Boone, D. L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0737048100 · Cited by 154
Cavalieri, S., Cazzaniga, S., Geuna, M., Magnani, Z., Bordignon, C., Naldini, L., & Bonini, C. (2003) · Blood · doi:10.1182/blood-2003-01-0297 · Cited by 153
Davis, I. D., Brady, B., Kefford, R. F., Millward, M., Cebon, J. S., Skrumsager, B. K., Mouritzen, U., Hansen, L. T., Skak, K., Lundsgaard, D., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2663 · Cited by 151
Li, Y., & Yee, C. (2007) · Blood · doi:10.1182/blood-2007-05-089375 · Cited by 150
Schliemann, C., Palumbo, A., Zuberbühler, K., Villa, A., Kaspar, M., Trachsel, E., Klapper, W., Menssen, H. D., & Neri, D. (2009) · Blood · doi:10.1182/blood-2008-05-160747 · Cited by 149
IL-21 inhibits T cell IL-2 production and impairs Treg homeostasis
Attridge, K., Wang, C. J., Wardzinski, L., Kenefeck, R., Chamberlain, J. L., Manzotti, C. N., Köpf, M., & Walker, L. S. K. (2012) · Blood · doi:10.1182/blood-2011-10-388546 · Cited by 149
Ex vivo expansion of human Tregs specific for alloantigens presented directly or indirectly
Veerapathran, A., Pidala, J., Beato, F., Yu, X., & Anasetti, C. (2011) · Blood · doi:10.1182/blood-2011-02-337097 · Cited by 147
Nishimura, H., Yajima, T., Naiki, Y., Tsunobuchi, H., Umemura, M., Itano, K., Matsuguchi, T., Suzuki, M., Ohashi, P. S., & Yoshikai, Y. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.1.157 · Cited by 147
Zhang, M., Yao, Z., Dubois, S. P., Ju, W., Müller, J. R., & Waldmann, T. A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0902637106 · Cited by 144
Mitchell, D. M., Ravkov, E. V., & Williams, M. A. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0904089 · Cited by 139
Interleukin 15 as a promising candidate for tumor immunotherapy
Jakóbisiak, M., Gołąb, J., & Lasek, W. (2011) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2011.04.001 · Cited by 135
IL-15 enhances survival and function of HIV-specific CD8+ T cells
Mueller, Y. M., Bojczuk, P. M., Halstead, E. S., Kim, A. H. J., Witek, J., Altman, J. D., & Katsikis, P. D. (2003) · Blood · doi:10.1182/blood-2002-07-1957 · Cited by 134
Human IL-2 Mutein with Higher Antitumor Efficacy Than Wild Type IL-2
Carmenate, T., Pacios, A., Enamorado, M., Moreno, E., Garcia-Martínez, K., Fuente, D., & León, K. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1201895 · Cited by 132
Interleukin-2-Dependent Mechanisms of Tolerance and Immunity In Vivo
Antony, P. A., Paulos, C. M., Ahmadzadeh, M., Akpınarlı, A., Palmer, D. C., Sato, N., Kaiser, A., Hinrichs, C. S., Klebanoff, C. A., Tagaya, Y., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.9.5255 · Cited by 131
de Totero, D., Meazza, R., Capaia, M., Fabbi, M., Azzarone, B. G., Balleari, E., Gobbi, M., Cutrona, G., Ferrarini, M., & Ferrini, S. (2007) · Blood · doi:10.1182/blood-2007-04-087882 · Cited by 128
Interleukin-21 Has Activity in Patients With Metastatic Melanoma: A Phase II Study
Petrella, T. M., Tozer, R., Belanger, K., Savage, K. J., Wong, R., Smylie, M., Kamel-Reid, S., Tron, V., Chen, B. E., Hunder, N. N., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.40.0655 · Cited by 126
Besser, M. J., Shapira-Frommer, R., Treves, A. J., Zippel, D., Itzhaki, O., Schallmach, E., Kubi, A., Shalmon, B., Hardan, I., Catane, R., et al. (2009) · Journal of Immunotherapy · doi:10.1097/cji.0b013e31819c8bda · Cited by 121
Phenotypic and functional characterization of human CD25+ B cells
Brisslert, M., Bokarewa, M., Larsson, P., Wing, K., Collins, L. V., & Tarkowski, A. (2006) · Immunology · doi:10.1111/j.1365-2567.2006.02331.x · Cited by 121
Wan, C.-K., Oh, J., Li, P., West, E. E., Wong, E. A., Andraski, A. B., Spolski, R., Yu, Z.-X., He, J., Kelsall, B. L., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.02.011 · Cited by 117
Kurys, G., Tagaya, Y., Bamford, R., Hanover, J. A., & Waldmann, T. A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002373200 · Cited by 115
In Vivo and In Vitro Roles of IL-21 in Inflammation
Pelletier, M., Bouchard, A., & Girard, D. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.12.7521 · Cited by 107
Immunocytokines: a review of molecules in clinical development for cancer therapy
List, T., & Neri, D. (2013) · Clinical Pharmacology Advances and Applications · doi:10.2147/cpaa.s49231 · Cited by 104
Liu, Z., Yang, L., Cui, Y., Wang, X., Guo, C., Huang, Z., Kan, Q., Liu, Z., & Liu, Y. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20923 · Cited by 103
Evans, R., Fuller, J. A., Christianson, G. J., Krupke, D. M., & Troutt, A. B. (1997) · Cellular Immunology · doi:10.1006/cimm.1997.1132 · Cited by 102
Santegoets, S. J. A. M., Turksma, A. W., Suhoski, M. M., Stam, A. G. M., Albelda, S., Hooijberg, E., Scheper, R. J., van den Eertwegh, A. J. M., Gerritsen, W. R., Powell, D. J., et al. (2013) · Journal of Translational Medicine · doi:10.1186/1479-5876-11-37 · Cited by 102
Lysis of fresh human solid tumors by autologous lymphocytes activated in vitro with lectins.
Mazumder, A., Grimm, E. A., Zhang, H. Z., & Rosenberg, S. A. (1982) · PubMed · Cited by 99
Cheng, G., Yu, A., Dee, M. J., & Malek, T. R. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1201218 · Cited by 99
Giron‐Michel, J., Giuliani, M., Fogli, M., Brouty‐Boyé, D., Ferrini, S., Baychelier, F., Eid, P., Bousse‐Kerdilès, M. L., Duralı, D., Biassoni, R., et al. (2005) · Blood · doi:10.1182/blood-2005-01-0064 · Cited by 99
Li, Y., Liu, S., Hernandez, J., Vence, L., Hwu, P., & Radvanyi, L. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0901101 · Cited by 97
Self-citationDjeu, J. Y., Liu, J. H., Wei, S., Rui, H., Pearson, C. A., Leonard, W. J., & Blanchard, D. K. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.3.960 · Cited by 92
IL-21 Promotes CD8+ CTL Activity via the Transcription Factor T-bet
Sutherland, A. P. R., Joller, N., Michaud, M., Liu, S. M., Kuchroo, V. K., & Grusby, M. J. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1201730 · Cited by 92
Activation of neutrophils by interleukins-1 and -2 and tumor necrosis factors.
Ferrante, A. (1992) · PubMed · Cited by 91
IL-21 Restricts Virus-driven Treg Cell Expansion in Chronic LCMV Infection
Schmitz, I., Schneider, C., Fröhlich, A., Frebel, H., Christ, D., Leonard, W. J., Sparwasser, T. D., Oxenius, A., Freigang, S., & Köpf, M. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003362 · Cited by 90
Chiossone, L., Vitale, C., Cottalasso, F., Moretti, S., Azzarone, B. G., Moretta, L., & Mingari, M. C. (2007) · Blood · doi:10.1182/blood-2006-07-037846 · Cited by 88
Assier, É., Jullien, V., Lefort, J., Moreau, J., Santo, J. P. D., Vargaftig, B. B., Silva, J. R. L. E., & Thèze, J. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.12.7661 · Cited by 88
Steele, N., Anthony, A., Saunders, M., Esmarck, B., Ehrnrooth, E., Kristjansen, P. E. G., Nihlén, A., Hansen, L. T., & Cassidy, J. (2012) · British Journal of Cancer · doi:10.1038/bjc.2011.599 · Cited by 87
IL-21 synergizes with IL-7 to augment expansion and anti-tumor function of cytotoxic T cells
Liu, S., Lizee, G. A., Lou, Y., Liu, C., Overwijk, W. W., Wang, G., & Hwu, P. (2007) · International Immunology · doi:10.1093/intimm/dxm093 · Cited by 86
IL-15 Fosters Age-Driven Regulatory T Cell Accrual in the Face of Declining IL-2 Levels
Raynor, J. L., Sholl, A., Plas, D. R., Bouillet, P., Chougnet, C. A., & Hildeman, D. A. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00161 · Cited by 83
Νάκου, Μ., Papadimitraki, E. D., Fanouriakis, A., Bertsias, G. K., Choulaki, C., Goulidaki, N., Sidiropoulos, P. I., & Boumpas, D. T. (2013) · PubMed · Cited by 82
IL‐15 acts as a potent inducer of CD4+CD25hi cells expressing FOXP3
Imamichi, H., Sereti, I., & Lane, H. C. (2008) · European Journal of Immunology · doi:10.1002/eji.200737607 · Cited by 82
Marzec, M., Liu, X., Kasprzycka, M., Witkiewicz, A. K., Raghunath, P. N., El-Salem, M., Robertson, E. S., Ødum, N., & Wasik, M. A. (2007) · Blood · doi:10.1182/blood-2007-06-095182 · Cited by 79
Pallikkuth, S., Pilakka‐Kanthikeel, S., Silva, S. Y., Fischl, M. A., Pahwa, R., & Pahwa, S. G. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100264 · Cited by 79
A Programmed Switch from IL-15- to IL-2-Dependent Activation in Human NK Cells
Pillet, A.-H., Bugault, F., Thèze, J., Chakrabarti, L. A., & Rose, T. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0801933 · Cited by 77
Schneider, R., Mohebiany, A. N., Ifergan, I., Beauseigle, D., Duquette, P., Prat, A., & Arbour, N. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100885 · Cited by 74
de Andrés, C., Tejera‐Alhambra, M., Alonso, B., Valor, L., Teijeiro, R., Ramos‐Medina, R., Mateos, D., Faure, F., & Sánchez‐Ramón, S. (2014) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2014.02.003 · Cited by 73
Perna, S. K., Angelis, B. D., Pagliara, D., Hasan, S. T., Zhang, L., Mahendravada, A., Heslop, H. E., Brenner, M. K., Rooney, C. M., Dotti, G., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2143 · Cited by 72
Yui, M. A., Sharp, L. L., Havran, W. L., & Rothenberg, E. V. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.8.4691 · Cited by 71
Khawam, K., Giron‐Michel, J., Gu, Y., Perier, A., Giuliani, M., Caignard, A., Devocelle, A., Ferrini, S., Fabbi, M., Charpentier, B., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3198 · Cited by 70
Timmerman, J. M., Byrd, J. C., Andorsky, D. J., Yamada, R. E., Kramer, J., Muthusamy, N., Hunder, N., & Pagel, J. M. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0456 · Cited by 69
Heaton, K. M., Ju, G., & Grimm, E. A. (1993) · PubMed · Cited by 67
Castro, I., Yu, A., Dee, M. J., & Malek, T. R. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003961 · Cited by 64
The Structure of the Interleukin-15α Receptor and Its Implications for Ligand Binding
Lorenzen, I., Dingley, A. J., Jacques, Y., & Grötzinger, J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m513118200 · Cited by 62
Recombinant interleukin-21 plus sorafenib for metastatic renal cell carcinoma: a phase 1/2 study
Bhatia, S., Curti, B., Ernstoff, M. S., Gordon, M., Heath, E. I., Miller, W. H., Puzanov, I., Quinn, D. I., Flaig, T. W., VanVeldhuizen, P., et al. (2014) · Journal for ImmunoTherapy of Cancer · doi:10.1186/2051-1426-2-2 · Cited by 56
Barzegar, C., Meazza, R., Pereno, R., Pottin-Clémenceau, C., SCUDELETTI, M., Brouty‐Boyé, D., Doucet, C., Taoufik, Y., Ritz, J., Musselli, C., et al. (1998) · Oncogene · doi:10.1038/sj.onc.1201775 · Cited by 53
Angiopoietin 2 Is a Potential Mediator of High-Dose Interleukin 2–Induced Vascular Leak
Gallagher, D. C., Bhatt, R. S., Parikh, S. M., Patel, P., Seery, V., McDermott, D. F., Atkins, M. B., & Sukhatme, V. P. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2509 · Cited by 52
Dubois, S. P., Shou, W., Haneline, L. S., Fleischer, S., Waldmann, T. A., & Müller, J. R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2335979100 · Cited by 52
Cao, S., Troutt, A. B., & Rustum, Y. M. (1998) · PubMed · Cited by 51
Barlic, J., McDermott, D. H., Merrell, M. N., Gonzales, J., Via, L. E., & Murphy, P. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406978200 · Cited by 50
Park, Y.-K., Shin, D., Cho, D., Kim, S., Lee, J., Shin, M., Ryang, D., Lee, J. S., Park, M., Yoon, J. H., et al. (2012) · PubMed · Cited by 50
Efficacy of IL‐2‐ versus IL‐15‐stimulated CD8 T cells in adoptive immunotherapy
Mueller, K., Schweier, O., & Pircher, H. (2008) · European Journal of Immunology · doi:10.1002/eji.200838426 · Cited by 48
Interleukin-2 and Its Effects in the Central Nervous System
Jiang, C., & Lu, C. (1998) · Neurosignals · doi:10.1159/000014541 · Cited by 45
Berntsen, A., Brimnes, M. K., Straten, P. T., & Svane, I. M. (2010) · Journal of Immunotherapy · doi:10.1097/cji.0b013e3181cd870f · Cited by 43
Expression of interleukin-2 receptor gamma chain on human neutrophils
Liu, H., Wei, S., Ussery, D. W., Epling-Burnette, P. K., Leonard, W. J., & Djeu, J. Y. (1994) · Blood · doi:10.1182/blood.v84.11.3870.bloodjournal84113870 · Cited by 43
Grünwald, V., Desar, I. M. E., Haanen, J. B. A. G., Fiedler, W., Mouritzen, U., Olsen, M. W. B., & van Herpen, C. M. L. (2010) · Acta Oncologica · doi:10.3109/0284186x.2010.509104 · Cited by 42
Interleukin (IL)-2 and IL-15 have different effects on human natural killer lymphocytes
Pillet, A.-H., Thèze, J., & Rose, T. (2011) · Human Immunology · doi:10.1016/j.humimm.2011.07.311 · Cited by 42
Interleukin-15 in Gene Therapy of Cancer
Ochoa, M. C., Mazzolini, G. D., Hervás‐Stubbs, S., Sanmamed, M. F., Berraondo, P., & Melero, I. (2012) · Current Gene Therapy · doi:10.2174/156652313804806561 · Cited by 39
Samlowski, W. E., Kondapaneni, M., Tharkar, S., McGregor, J. R., Laubach, V. E., & Salvemini, D. (2011) · Journal of Immunotherapy · doi:10.1097/cji.0b013e31821dcb50 · Cited by 37
Effect of exposure to interleukin-21 at various time points on human natural killer cell culture
Lim, D., Jang, Y.-Y., Kim, S., Koh, S. S., Lee, J., Kim, J.-S., Phan, M. T., Shin, D., Shin, M., Lee, S., et al. (2014) · Cytotherapy · doi:10.1016/j.jcyt.2014.04.008 · Cited by 33
Comparison of vascular leak syndrome in mice treated with IL21 or IL2.
Sivakumar, P. V., García, R., Waggie, K. S., Anderson-Haley, M., Nelson, A., & Hughes, S. D. (2013) · Europe PMC (PubMed Central) · Cited by 32
Instruction of Treg commitment in peripheral T cells is suited to reverse autoimmunity
Jaeckel, E., Kretschmer, K., Apostolou, I., & von Boehmer, H. (2006) · Seminars in Immunology · doi:10.1016/j.smim.2006.01.011 · Cited by 30
Guo, W., Zheng, D.-H., Sun, F., Yang, J.-Y., Zang, Z.-L., Liu, S., Yin, Q., Zhang, C., & Yang, H. (2014) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000042 · Cited by 25
Carey, P. D., Wakefield, C. H., & Guillou, P. J. (1997) · Surgery · doi:10.1016/s0039-6060(97)90333-0 · Cited by 24
IL‐21 Modulates Activation of NKT Cells in Patients with Stage IV Malignant Melanoma
Coquet, J. M., Skak, K., Davis, I. D., Smyth, M. J., & Godfrey, D. I. (2013) · Clinical & Translational Immunology · doi:10.1038/cti.2013.7 · Cited by 24
Itoi, K., Sugimoto, N., Suzuki, S., Sawada, K., Das, G., Uchida, K., Fuse, T., Ohara, S., & Kobayashi, K. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.5188-10.2011 · Cited by 24
Response of Human Oligodendrocytes to Interleukin-2
Otero, G. C., & Merrill, J. E. (1997) · Brain Behavior and Immunity · doi:10.1006/brbi.1997.0475 · Cited by 23
He, H., Ni, B., Tian, Y., Tian, Z., Chen, Y., Liu, Z., Yang, X., Lv, Y., & Zhang, Y. (2013) · Immunology · doi:10.1111/imm.12198 · Cited by 17
IL-21 and IRF4: A Complex Partnership in Immune and Metabolic Regulation
Knudsen, N. H., & Lee, C. (2014) · Diabetes · doi:10.2337/db14-0273 · Cited by 11
Cited by
Melief, C. J. M., van Hall, T., Arens, R., Ossendorp, F., & van der Burg, S. H. (2015) · Journal of Clinical Investigation · doi:10.1172/jci80009 · Cited by 1,164
Immune escape to PD-L1/PD-1 blockade: seven steps to success (or failure)
Kim, J. M., & Chen, D. S. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw217 · Cited by 648
Role of IL-2 in cancer immunotherapy
Jiang, T., Zhou, C., & Ren, S. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1163462 · Cited by 549
CD4 and CD8 T lymphocyte interplay in controlling tumor growth
Ostroumov, D., Fekete-Drimusz, N., Saborowski, M., Kühnel, F., & Woller, N. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2686-7 · Cited by 549
Cytokines in the Treatment of Cancer
Conlon, K. C., Miljkovic, M. D., & Waldmann, T. A. (2019) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2018.0019 · Cited by 518
Metadata
- Authors
- Sim, G. C., & Radvanyi, L.
- Venue
- Cytokine & Growth Factor Reviews
- Publisher
- Elsevier BV
- Published
- 2014-08
- Volume
- 25
- Issue
- 4
- Pages
- 377-390
- ISSN
- 1359-6101 (ISSN-L)
- OpenAlex
- W2044315378
- Cited by
- 278
- References
- 183
- FWCI
- 2.07
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.